annual shareholders equity:
$1.93B+$49.28M(+2.62%)Summary
- As of today (June 29, 2025), CRSP annual stockholders equity is $1.93 billion, with the most recent change of +$49.28 million (+2.62%) on December 31, 2024.
- During the last 3 years, CRSP annual shareholders equity has fallen by -$467.38 million (-19.48%).
- CRSP annual shareholders equity is now -19.48% below its all-time high of $2.40 billion, reached on December 31, 2021.
Performance
CRSP Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$1.83B-$102.92M(-5.33%)Summary
- As of today (June 29, 2025), CRSP quarterly stockholders equity is $1.83 billion, with the most recent change of -$102.92 million (-5.33%) on March 31, 2025.
- Over the past year, CRSP quarterly shareholders equity has dropped by -$254.78 million (-12.23%).
- CRSP quarterly shareholders equity is now -29.75% below its all-time high of $2.60 billion, reached on June 30, 2021.
Performance
CRSP quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CRSP Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.6% | -12.2% |
| 3 y3 years | -19.5% | -18.5% |
| 5 y5 years | +105.7% | +106.4% |
CRSP Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.5% | +3.0% | -18.5% | +5.9% |
| 5 y | 5-year | -19.5% | +105.7% | -29.8% | +106.4% |
| alltime | all time | -19.5% | +6740.1% | -29.8% | +3027.6% |
CRSP Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.83B(-5.3%) |
| Dec 2024 | $1.93B(+2.6%) | $1.93B(-0.4%) |
| Sep 2024 | - | $1.94B(-2.1%) |
| Jun 2024 | - | $1.98B(-4.9%) |
| Mar 2024 | - | $2.08B(+10.7%) |
| Dec 2023 | $1.88B(+0.4%) | $1.88B(+9.0%) |
| Sep 2023 | - | $1.73B(-4.9%) |
| Jun 2023 | - | $1.82B(-2.1%) |
| Mar 2023 | - | $1.85B(-1.1%) |
| Dec 2022 | $1.88B(-21.8%) | $1.88B(-4.0%) |
| Sep 2022 | - | $1.95B(-6.5%) |
| Jun 2022 | - | $2.09B(-6.9%) |
| Mar 2022 | - | $2.24B(-6.4%) |
| Dec 2021 | $2.40B(+44.2%) | $2.40B(-4.5%) |
| Sep 2021 | - | $2.51B(-3.5%) |
| Jun 2021 | - | $2.60B(+44.2%) |
| Mar 2021 | - | $1.81B(+8.5%) |
| Dec 2020 | $1.66B | $1.66B(+23.9%) |
| Sep 2020 | - | $1.34B(+47.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $910.67M(+2.8%) |
| Mar 2020 | - | $886.10M(-5.7%) |
| Dec 2019 | $939.42M(+139.5%) | $939.42M(+58.7%) |
| Sep 2019 | - | $591.88M(+61.0%) |
| Jun 2019 | - | $367.68M(-3.2%) |
| Mar 2019 | - | $379.81M(-3.2%) |
| Dec 2018 | $392.19M(+108.8%) | $392.19M(-6.0%) |
| Sep 2018 | - | $417.31M(+57.4%) |
| Jun 2018 | - | $265.15M(-8.7%) |
| Mar 2018 | - | $290.33M(+54.6%) |
| Dec 2017 | $187.83M(-19.3%) | $187.83M(+5.0%) |
| Sep 2017 | - | $178.96M(-9.5%) |
| Jun 2017 | - | $197.80M(-8.1%) |
| Mar 2017 | - | $215.18M(-7.6%) |
| Dec 2016 | $232.85M(-900.2%) | $232.85M(-472.7%) |
| Sep 2016 | - | -$62.48M(-146.2%) |
| Jun 2016 | - | $135.34M(-565.1%) |
| Dec 2015 | -$29.10M(+308.8%) | -$29.10M |
| Dec 2014 | -$7.12M | - |
FAQ
- What is CRISPR Therapeutics AG annual stockholders equity?
- What is the all time high annual shareholders equity for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual shareholders equity year-on-year change?
- What is CRISPR Therapeutics AG quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly shareholders equity year-on-year change?
What is CRISPR Therapeutics AG annual stockholders equity?
The current annual shareholders equity of CRSP is $1.93B
What is the all time high annual shareholders equity for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual stockholders equity is $2.40B
What is CRISPR Therapeutics AG annual shareholders equity year-on-year change?
Over the past year, CRSP annual stockholders equity has changed by +$49.28M (+2.62%)
What is CRISPR Therapeutics AG quarterly stockholders equity?
The current quarterly shareholders equity of CRSP is $1.83B
What is the all time high quarterly shareholders equity for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly stockholders equity is $2.60B
What is CRISPR Therapeutics AG quarterly shareholders equity year-on-year change?
Over the past year, CRSP quarterly stockholders equity has changed by -$254.78M (-12.23%)